Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 19 January 2006. doi:10.1136/gut.2005.082701
Gut 2006;55:1174-1182
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2005.082701v1
55/8/1174    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Novo, E
Right arrow Articles by Parola, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Novo, E
Right arrow Articles by Parola, M
Topic Collections
Right arrowRelevant Article

LIVER DISEASE

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans

E Novo1, F Marra2, E Zamara1, L Valfrè di Bonzo1, L Monitillo1, S Cannito1, I Petrai2, A Mazzocca2, A Bonacchi2, R S M De Franco2, S Colombatto1, R Autelli1, M Pinzani2, M Parola1

1 Dip Medicina e Oncologia Sperimentale, University of Torino, Italy
2 Dip Medicina Interna-Centro di Ricerca, Trasferimento e Alta Formazione "DENOTHE", University of Florence, Italy

Correspondence to:
Correspondence to:
Professor M Parola
Università degli Studi di Torino, Dip Medicina e Oncologia Sperimentale, C so Raffaello 30, 10125 Torino, Italy; maurizio.parola{at}unito.it

Background and aims: Myofibroblast-like cells, originating from activation of hepatic stellate cells (HSC/MFs), play a key role in liver fibrosis, a potentially reversible process that may rely on induction of HSC/MFs apoptosis. While this possibility has been shown in cultured rat HSC, very limited data are currently available for human HSC/MFs.

Methods: Cultured human HSC/MFs were exposed to several proapoptotic stimuli, including those known to induce apoptosis in rat HSC/MFs, and induction of cell death and related mechanisms were investigated using morphology, molecular biology, and biochemical techniques.

Results: In this study we report that fully activated human HSC/MFs did not undergo spontaneous apoptosis and survived to prolonged serum deprivation, Fas activation, or exposure to nerve growth factor, tumour necrosis factor {alpha} (TNF-{alpha}), oxidative stress mediators, doxorubicin, and etoposide. Induction of caspase dependent, mitochondria driven apoptosis in HSC/MFs was observed only when protein synthesis or transcription were inhibited. Importantly, the process of HSC activation was accompanied by changes in expression of a set of genes involved in apoptosis control. In particular, activated human HSC/MFs in culture overexpressed Bcl-2. The role of Bcl-2 was crucial as Bcl-2 silenced cells became susceptible to TNF-{alpha} induced apoptosis. Finally, Bcl-2 was markedly expressed in HSC/MFs present in liver tissue obtained from patients with hepatitis C virus related cirrhosis.

Conclusions: Human activated HSC/MFs are resistant to most proapoptotic stimuli due to Bcl-2 overexpression and this feature may play a key role in the progression of fibrosis in chronic liver diseases.


Abbreviations: CLDs, chronic liver diseases; DAPI, 4,6-diamidine-2-phenylindole di-hydrochloride; {Delta}{psi}m, mitochondrial membrane potential; ECL, enhanced chemiluminescence; ERK, extracellular regulated kinase; FasL, Fas ligand; HCV, hepatitis C virus; HSC, hepatic stellate cells; HSC/MFs, activated hepatic stellate cells in myofibroblast-like phenotype; JC-1, J-aggregate forming lipophilic cation; LDH, lactate dehydrogenase; mAb, monoclonal antibody; NGF, nerve growth factor; NF{kappa}B, nuclear factor {kappa}B; PARP, poly (ADP ribose) polymerase; SFI medium, serum free Iscove’s medium; {alpha}-SMA, {alpha} smooth muscle actin; siRNA, small interfering RNA; TBS, Tris buffered saline; h-TERT, human telomerase catalytic subunit; TIMP, tissue inhibitor of metalloproteinases; TNF-{alpha}, tumour necrosis factor {alpha}; TrkA, tyrosine kinase A

Keywords: activated human hepatic stellate cells; liver fibrosis; apoptosis; Bcl-2; induction of cell death


Relevant Article

Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease
N Kawada
Gut 2006 55: 1073-1074. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. Novo, S. Cannito, E. Zamara, L. V. di Bonzo, A. Caligiuri, C. Cravanzola, A. Compagnone, S. Colombatto, F. Marra, M. Pinzani, et al.
Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells
Am. J. Pathol., June 1, 2007; 170(6): 1942 - 1953.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. A. Passino, R. A. Adams, S. L. Sikorski, and K. Akassoglou
Regulation of Hepatic Stellate Cell Differentiation by the Neurotrophin Receptor p75NTR
Science, March 30, 2007; 315(5820): 1853 - 1856.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N Kawada
Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease.
Gut, August 1, 2006; 55(8): 1073 - 1074.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology